Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial

BACKGROUND: Pneumocystis pneumonia (PCP) is a common acquired immune deficiency syndrome (AIDS)-related opportunistic infection. Recent reports estimate that more than 400,000 patients with human immunodeficiency virus (HIV) develop PCP each year globally. However, the timing of antiretroviral thera...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Trials
Päätekijät: Qin, Yuanyuan, Lu, Yanqiu, Zhou, Yihong, Harypursat, Vijay, Sun, Feng, Yang, Sen, Tang, Shengquan, Li, Yao, He, Xiaoqing, Zeng, Yanming, Chen, Yaokai
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7310256/
https://ncbi.nlm.nih.gov/pubmed/32571429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04450-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia